2008
DOI: 10.1002/gps.2145
|View full text |Cite|
|
Sign up to set email alerts
|

White‐coat effect among older patients with suspected cognitive impairment: prevalence and clinical implications

Abstract: ObjectivesTo evaluate the prevalence of white‐coat effect (WCE), and its association with individual anxiety and insight of disease, among older patients evaluated for suspected cognitive impairment.MethodsThis prospective cohort study, conducted in an Alzheimer Evaluation Unit, involved patients aged 55 years or older with suspected cognitive impairment. WCE was defined as a difference of at least 20 mmHg in systolic or 10 mmHg in diastolic blood pressure (BP) measured either by a physician during the visit o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 29 publications
0
9
0
Order By: Relevance
“…Therefore, the WCE in the clinical or pharmacy setting introduces an error in the BP measurement, which can lead to mistakes in clinical evaluations and therapeutic decision-making, including overdiagnosis of hypertension, underestimation of the effectiveness of treatment, or the use of unnecessary medication. This may result in the increased risk of undesirable effects of the medication and/or health care spending [2,3]. To avoid the possible consequences of the WCE, the optimal solution is to use BP measurement methods that, as they are applied outside a clinical setting, are exempt from that effect [4], such as home BP (HBP) monitoring (HBPM) and ambulatory BP (ABP) monitoring (ABPM).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the WCE in the clinical or pharmacy setting introduces an error in the BP measurement, which can lead to mistakes in clinical evaluations and therapeutic decision-making, including overdiagnosis of hypertension, underestimation of the effectiveness of treatment, or the use of unnecessary medication. This may result in the increased risk of undesirable effects of the medication and/or health care spending [2,3]. To avoid the possible consequences of the WCE, the optimal solution is to use BP measurement methods that, as they are applied outside a clinical setting, are exempt from that effect [4], such as home BP (HBP) monitoring (HBPM) and ambulatory BP (ABP) monitoring (ABPM).…”
Section: Introductionmentioning
confidence: 99%
“…Using paired sample t-tests, mean hSBP was slightly lower than mean oSBP (t (132) = -2.2, p < .05 two-tailed), though this difference was not as pronounced as typically found in previous studies [20, 23]. Mean hPP was slightly lower than mean oPP (M = 52.7, SD = 9.5, t (132) = -2.0, p < .05 two-tailed).…”
Section: Resultsmentioning
confidence: 55%
“…Over 50% of older outpatients attending their first visit for a cognitive evaluation are estimated to have substantial white coat hypertension [23], which could lead to overestimations of hypertensive severity [18]. Home readings also identify individuals with masked hypertension and prehypertension who are at increased risk for cognitive dysfunction and stroke [8].…”
Section: Introductionmentioning
confidence: 99%
“…However, classical tests have some relevant limitations, such as being perceived as intrusive ( Chaytor & Schmitter-Edgecombe, 2003 ), being influenced by the white-coat effect ( Mario et al, 2009 ), providing a late diagnosis ( Holtzman, Morris & Goate, 2011 ), lacking ecological validity ( Farias et al, 2003 ; Knight & Titov, 2009 ); being strongly dependent on confounding factors (e.g., age, educational level ( Cordell et al, 2013 ), practice effect ( Hawkins, Dean & Pearlson, 2004 ; Lezak, 2004 )), or being prone to processing errors due to their manual processing.…”
Section: Introductionmentioning
confidence: 99%